Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;5(1):51-55.
doi: 10.1016/j.glohj.2021.02.005. Epub 2021 Feb 9.

Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States

Affiliations
Review

Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States

Yanjie Zhang et al. Glob Health J. 2021 Mar.

Abstract

To date, the United States (U.S.) has been the most heavily impacted country by the coronavirus disease 2019 (COVID-19). By November 30, 2020, when this paper was written, 13.5 million cases were reported in the U.S. with over 268 000 deaths. Historically, vaccines have been one of the most effective and efficient technical tools for controlling a communicable disease. While the development of these vaccines has certainly been a challenge, it could be more challenging to achieve robust vaccine uptake because of many barriers. In this review, we focused on two types of barriers documented from long-term experience in the U.S.: structural and attitudinal. Structural barriers are systemic issues that impact one's ability to access a service, and they include time, transportation, cost, and clinic or outlet location; while attitudinal barriers are beliefs or perceptions that impact the willingness of at-risk individuals to seek out and/or accept a service. In the context of vaccination they include beliefs about the communicable disease, beliefs about vaccines, fear, and trust in healthcare and governmental agencies. Of the attitudinal barriers, public trust is a barrier that is of particular importance. In addition to affecting reception of vaccines, it may exacerbate disparities and reduce the likelihood of success of a vaccination program. Recommendations are made to overcome attitudinal barriers to help improve the effectiveness of vaccination programs for COVID-19 control in the U.S., such as building public support through bipartisan endorsements and leveraging social media platforms to promote vaccination.

Keywords: Attitudinal barriers; Coronavirus disease 2019 (COVID-19); Structural barriers; The United States; Vaccination.

PubMed Disclaimer

References

    1. CDC COVID-19 Response Team, Jorden MA, Rudman SL, CDC COVID-19 Response Team Evidence for limited early spread of COVID-19 within the United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(22):680–684. doi: 10.15585/mmwr.mm6922e1. - DOI - PMC - PubMed
    1. COVID-19 United States cases by County. Johns Hopkins Coronavirus Resource Center website. https://coronavirus.jhu.edu/us-map. Accessed October 4, 2020.
    1. FDA Takes Key Action in Fight Against COVID-19 by Issuing Emergency Use Authorization for First COVID-19 Vaccine. U.S. Food & Drug Administration website. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action.... Accessed December 22, 2020.
    1. FDA Takes Additional Action in Fight Against COVID-19 by Issuing Emergency Use Authorization for second COVID-19 Vaccine. U.S. Food & Drug Administration website. https://www.fda.gov/news-events/press-announcements/fda-takes-additional.... Accessed December 24, 2020.
    1. Chen G, Kazmi M, Chen D, Phillips J. Identifying associations between influenza vaccination status and access, beliefs, and sociodemographic factors among the uninsured population in Suffolk County, NY. J Community Health. 2020;45(6):1236–1241. doi: 10.1007/s10900-020-00873-1. - DOI - PubMed